Related references
Note: Only part of the references are listed.Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis
Shuangge Liu et al.
PLOS ONE (2016)
Distinct β-Catenin and PIK3CA Mutation Profiles in Endometriosis-Associated Ovarian Endometrioid and Clear Cell Carcinomas
Toshihide Matsumoto et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro
Sachiko Matsuzaki et al.
HUMAN REPRODUCTION (2015)
Current Strategies for Endometriosis Management
Pinar H. Kodaman
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2015)
Angiogenesis as a Therapeutic Target in Endometriosis
Dusan Djokovic et al.
ACTA MEDICA PORTUGUESA (2014)
Marine Compound Catunaregin Inhibits Angiogenesis through the Modulation of Phosphorylation of Akt and eNOS in vivo and in vitro
Jun-Xiu Liu et al.
MARINE DRUGS (2014)
Protocatechuic Acid Induces Angiogenesis through PI3K-Akt-eNOS-VEGF Signalling Pathway
Zechun Kang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Increased Expression of Pattern Recognition Receptors and Nitric Oxide Synthase in Patients with Endometriosis
Seung Geun Yeo et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells
Jae-Won Kim et al.
CANCER BIOLOGY & THERAPY (2012)
Anti-angiogenic treatment strategies for the therapy of endometriosis
M. W. Laschke et al.
HUMAN REPRODUCTION UPDATE (2012)
The mTOR/AKT Inhibitor Temsirolimus Prevents Deep Infiltrating Endometriosis in Mice
Mahaut Leconte et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
17βE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFκB-dependent pathway
Hui Zhang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Recurrence of endometriosis and its control
Sun-Wei Guo
HUMAN REPRODUCTION UPDATE (2009)
Antiangiogenic agents are effective inhibitors of endometriosis
ML Hull et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications
N Ferrara
SEMINARS IN ONCOLOGY (2002)
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
M Mayerhofer et al.
BLOOD (2002)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
Immunohistochemical analysis of the role of angiogenic status in the vasculature of peritoneal endometriosis
S Matsuzaki et al.
FERTILITY AND STERILITY (2001)
Share Paper
